Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Retraction notice to "Supplier selection in green supply chain management using correlation-based TOPSIS in a q-rung orthopair fuzzy soft environment" [Heliyon 10 (2024) e32145]. [PDF]
Zulqarnain RM +5 more
europepmc +1 more source
Investigating the COVID-19 pandemic's impact on sustainable supplier selection in the Nigerian manufacturing sector. [PDF]
Orji IJ, Ojadi F.
europepmc +1 more source
PROPOSAL OF AN EMPIRICAL MODEL FOR SUPPLIERS SELECTION
The problem of selecting suppliers/partners is a crucial and important part in the process of decision making for companies that intend to perform competitively in their area of activity. The selection of supplier/partner is a time and resource-consuming task that involves data collection and a careful analysis of the factors that can positively or ...
Ávila, P. +6 more
openaire +2 more sources
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Enhancing green supplier selection: A nonlinear programming method with TOPSIS in cubic Pythagorean fuzzy contexts. [PDF]
Khan M, Chao W, Rahim M, Amin F.
europepmc +1 more source
Fermatean Fuzzy Schweizer-Sklar Operators and BWM-Entropy-Based Combined Compromise Solution Approach: An Application to Green Supplier Selection. [PDF]
Wei D +5 more
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Digital twin and fuzzy framework for supply chain sustainability risk assessment and management in supplier selection. [PDF]
Hezam IM +4 more
europepmc +1 more source

